For patients with Crohn's and Colitis diseases, fecal matter transplants could be the therapy they have been waiting for. Dr. Neil Nandi, Director of the Center for Inflammatory Bowel Diseases at Drexel University College of Medicine, will discuss what fecal transplants are, outline the risks and benefits of treatment, and forecast upcoming research. He is joined by Rebecca Kaplan of the Crohn's and Colitis Foundation.
- Medical Therapy
How will Small Molecule Therapies Change Management of ASUC
Amar Naik, MDPeer